CCL18 and neoplasm: Interestingly, CCL18-activated NBFs, but not TGF-β-treated NBFs, enhanced the survival of cocultured tumor cells exposed to the chemotherapeutic docetaxel or cisplatin (Fig. 4B and Supplementary Fig. 4B).